Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-25 17:45 |
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY…
|
English | 119.4 KB | ||
| 2025-06-05 17:45 |
Valneva annonce des résultats positifs de Phase 2 à six mois sur la persistance…
|
French | 236.5 KB | ||
| 2025-06-05 17:45 |
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Resu…
|
English | 178.3 KB | ||
| 2025-06-05 07:30 |
[Valneva SE] Déclaration d’actions et de droits de vote - mai 2025
|
French | 160.2 KB | ||
| 2025-06-05 07:30 |
[Valneva SE] Declaration of shares and voting rights - May 2025
|
English | 170.0 KB | ||
| 2025-06-04 07:00 |
Valneva annonce la mise à disposition des documents préparatoires à son Assembl…
|
French | 115.0 KB | ||
| 2025-06-04 07:00 |
Valneva Announces Availability of Documentation for its Combined Shareholder Me…
|
English | 122.8 KB | ||
| 2025-05-26 17:30 |
Valneva participera à différentes conférences d’investisseurs aux États-Unis et…
|
French | 150.8 KB | ||
| 2025-05-26 17:30 |
Valneva to Participate at U.S. and European Investor Conferences in June
|
English | 120.9 KB | ||
| 2025-05-12 07:00 |
Valneva fait un point sur les recommandations d’utilisation d'IXCHIQ® chez les …
|
French | 163.7 KB | ||
| 2025-05-12 07:00 |
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in…
|
English | 138.7 KB | ||
| 2025-05-07 18:00 |
VALNEVA Declaration of shares and voting rights: April 30, 2025
|
English | 14.2 KB | ||
| 2025-05-07 18:00 |
VALNEVA Déclaration d’actions et de droits de vote : 30 avril 2025
|
French | 14.5 KB | ||
| 2025-05-07 17:45 |
Valneva fait un point suite à l'annonce de l'agence européenne des médicaments …
|
French | 160.3 KB | ||
| 2025-05-07 17:45 |
Valneva Provides Update Following European Medicines Agency Announcement on Use…
|
English | 173.0 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
